Evidence map›Paper›PMID 27896360›Full record

ArticleJournal of biomedical optics2016

Optical redox imaging indices discriminate human breast cancer from normal tissues.

He N Xu, Julia Tchou, Min Feng, Huaqing Zhao, Lin Z Li

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomedical optics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Qualitative and quantitative assessment ofBiomedical optics express · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

He N XuUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Molecular Imaging Laboratory, B6 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104, United StatesbUniversity of Pennsylvania, Perelman School of Medicine, Department of Biochemistry and Biophysics, Johnson Research Foundation, Britton Chance Laboratory of Redox Imaging, R171 John Morgan Building, 3620 Hamilton Walk, Philadelphia, Pennsylvania 19104, United States.
Julia TchouUniversity of Pennsylvania, Perelman School of Medicine, Division of Endocrine and Oncologic Surgery, Department of Surgery, West Pavilion 3rd Floor, 3400 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, United StatesdUniversity of Pennsylvania, Perelman School of Medicine, Abramson Cancer Center, 3400 Spruce Street, Philadelphia, Pennsylvania 19104, United StateseUniversity of Pennsylvania, Perelman School of Medicine, Rena Rowan Breast Center, West Pavilion, 3rd Floor, 3400 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, United States.
Min FengUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Molecular Imaging Laboratory, B6 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104, United StatesbUniversity of Pennsylvania, Perelman School of Medicine, Department of Biochemistry and Biophysics, Johnson Research Foundation, Britton Chance Laboratory of Redox Imaging, R171 John Morgan Building, 3620 Hamilton Walk, Philadelphia, Pennsylvania 19104, United States.
Huaqing ZhaoTemple University, School of Medicine, Department of Clinical Sciences, Kresge Room 218, 3440 North Broad Street, Philadelphia, Pennsylvania 19140, United States.
Lin Z LiUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Molecular Imaging Laboratory, B6 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104, United StatesbUniversity of Pennsylvania, Perelman School of Medicine, Department of Biochemistry and Biophysics, Johnson Research Foundation, Britton Chance Laboratory of Redox Imaging, R171 John Morgan Building, 3620 Hamilton Walk, Philadelphia, Pennsylvania 19104, United StatesdUniversity of Pennsylvania, Perelman School of Medicine, Abramson Cancer Center, 3400 Spruce Street, Philadelphia, Pennsylvania 19104, United States.
University of Pennsylvania · USTemple College · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Training and DisseminationP41EB015893 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI REDDY, RAVINDER · 2012 to 2019
$11.3M
Redox imaging for breast cancer prognosisR01CA191207 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, LIN Z · 2015 to 2019
$3.2M
Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MRR01CA155348 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, LIN Z · 2011 to 2015
$1.9M
NCI NIH HHS P30 CA016520NCI NIH HHS R01 CA155348NCI NIH HHS R01 CA191207NIBIB NIH HHS P41 EB015893
6 · The paper itself

Abstract

Our long-term goal was to investigate the potential of incorporating redox imaging technique as a breast cancer (BC) diagnosis component to increase the positive predictive value of suspicious imaging finding and to reduce unnecessary biopsies and overdiagnosis. We previously found that precancer and cancer tissues in animal models displayed abnormal mitochondrial redox state. We also revealed abnormal mitochondrial redox state in cancerous specimens from three BC patients. Here, we extend our study to include biopsies of 16 patients. Tissue aliquots were collected from both apparently normal and cancerous tissues from the affected cancer-bearing breasts shortly after surgical resection. All specimens were snap-frozen and scanned with the Chance redox scanner, i.e., the three-dimensional cryogenic NADH/Fp (reduced nicotinamide adenine dinucleotide/oxidized flavoproteins) fluorescence imager. We found both Fp and NADH in the cancerous tissues roughly tripled that in the normal tissues ( p < 0.05 ). The redox ratio Fp/(NADH + Fp) was ? 27 % higher in the cancerous tissues ( p < 0.05 ). Additionally, Fp, or NADH, or the redox ratio alone could predict cancer with reasonable sensitivity and specificity. Our findings suggest that the optical redox imaging technique can provide parameters independent of clinical factors for discriminating cancer from noncancer breast tissues in human patients.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorBiopsyBreastBreast NeoplasmsFemaleFlavin-Adenine DinucleotideHumansImage Interpretation, Computer-AssistedMiddle AgedMitochondriaMolecular ImagingNADOxidation-ReductionBiomarkers, TumorFlavin-Adenine DinucleotideNAD

Identifiers

PMID27896360
PMCPMC5136669
OpenAlexW2558664056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.